Propranolol for infantile haemangiomas: Initiating treatment on an outpatient basis

Cardiology in the Young

Volumn 22, Issue 4, 2012, Pages 424-429

  Dyme, Joshua L ^a   Thampan, Ashis ^b   Han, Eugenia J ^b   Nyirenda, Themba L ^a   Kotb, Mohy E ^b   Shin, Helen T ^a  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Beta blocker; hypoglycaemia; infant

Indexed keywords

PROPRANOLOL;

ARTICLE; BRADYCARDIA; BRONCHOSPASM; CAPILLARY HEMANGIOMA; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ARTICLE; CLINICAL OBSERVATION; COHORT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FOLLOW UP; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INFANT; MEDICAL RECORD REVIEW; OUTPATIENT CARE; PATIENT MONITORING; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEMANGIOMA; HUMANS; INFANT; MALE; OUTPATIENTS; PROPRANOLOL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84863670767     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951111001946     Document Type: Article

References (12)

1. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008; 122: 360-367.
2. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
3. Gillette P, Garson A Jr, Eterovic E, Neeches W, Mullins C, McNamara DG. Oral propranolol treatment in infants and children. J Pediatr 1978; 92: 141-144.
4. Lawley LP, Sigfried E, Todd JL. Propranolol treatment for hemangiomas of infancy: risks and recommendations. Pediatr Dermatol 2009; 26: 610-614.
5. Breur JM, de Graaf M, Breugem CC, Pasmans SG. Hypoglycemia as a result of propranolol treatment of infantile hemangioma: a case report. Pediatr Dermatol 2011; 28: 169-171.
6. Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010; 146: 775-778.
7. Custer JW, Rau RE. (eds.) The Harriet Lane Handbook: a Manual for Pediatric House Officers. Mosby, Philadelphia, 2009.
8. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 2010; 120: 676-681.
9. Cushing SL, Boucek RJ, Manning SC, Sidbury R, Perkins JA. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas. Otolaryngol Head Neck Surg 2011; 144: 78-84.
10. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-274.
11. Ozeki M, Fukao T, Kondo N. Propranolol for intractable diffuse lymphangiomatosis. N Engl J Med 2011; 364: 1380-1382.
12. Hermans DJJ, van Beynum IM, van der Vijver RJ, Jan Schultze Kool L, de Blaauw I, van der Vleuten CJM. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment. J Pediatr Hematol Oncol 2011; 33: e171-e173.